LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | PD0325901 | 0.37 | uM | LJP5 | 72 | hr | 1389 | 3616 | 5667 | 0.6380 | 0.5205 |
MCF7 | PD0325901 | 0.37 | uM | LJP6 | 72 | hr | 1389 | 3098 | 5667 | 0.5466 | 0.3995 |
MCF7 | PD173074 | 0.37 | uM | LJP6 | 72 | hr | 1389 | 5549 | 5667 | 0.9791 | 0.9724 |
MCF7 | PD184352 | 0.37 | uM | LJP5 | 72 | hr | 1389 | 4444 | 5667 | 0.7841 | 0.7140 |
MCF7 | Pelitinib | 0.37 | uM | LJP5 | 72 | hr | 1389 | 5272 | 5667 | 0.9302 | 0.9076 |
MCF7 | PF431396 | 0.37 | uM | LJP5 | 72 | hr | 1389 | 2289 | 5667 | 0.4039 | 0.2104 |
MCF7 | PF477736 | 0.37 | uM | LJP5 | 72 | hr | 1389 | 2726 | 5667 | 0.4810 | 0.3126 |
MCF7 | PF562271 | 0.37 | uM | LJP6 | 72 | hr | 1389 | 3527 | 5667 | 0.6224 | 0.4998 |
MCF7 | PHA-665752 | 0.37 | uM | LJP5 | 72 | hr | 1389 | 6395 | 5667 | 1.1284 | 1.1700 |
MCF7 | PHA-793887 | 0.37 | uM | LJP6 | 72 | hr | 1389 | 1696 | 5667 | 0.2994 | 0.0719 |
MCF7 | PI103 | 0.37 | uM | LJP6 | 72 | hr | 1389 | 1654 | 5667 | 0.2919 | 0.0621 |
MCF7 | PLX-4720 | 0.37 | uM | LJP5 | 72 | hr | 1389 | 6284 | 5667 | 1.1088 | 1.1441 |
MCF7 | QL-X-138 | 0.37 | uM | LJP6 | 72 | hr | 1389 | 2730 | 5667 | 0.4817 | 0.3135 |
MCF7 | QL-XII-47 | 0.37 | uM | LJP6 | 72 | hr | 1389 | 1728 | 5667 | 0.3050 | 0.0794 |
MCF7 | Radicicol | 0.37 | uM | LJP5 | 72 | hr | 1389 | 1571 | 5667 | 0.2773 | 0.0426 |
MCF7 | Radicicol | 0.37 | uM | LJP6 | 72 | hr | 1389 | 1699 | 5667 | 0.2998 | 0.0725 |
MCF7 | Seliciclib | 0.37 | uM | LJP5 | 72 | hr | 1389 | 5718 | 5667 | 1.0089 | 1.0118 |
MCF7 | Ruxolitinib | 0.37 | uM | LJP5 | 72 | hr | 1389 | 5681 | 5667 | 1.0023 | 1.0031 |
MCF7 | XL147 | 0.37 | uM | LJP5 | 72 | hr | 1389 | 6139 | 5667 | 1.0832 | 1.1102 |
MCF7 | Saracatinib | 0.37 | uM | LJP6 | 72 | hr | 1389 | 2345 | 5667 | 0.4137 | 0.2234 |
MCF7 | Selumetinib | 0.37 | uM | LJP6 | 72 | hr | 1389 | 3295 | 5667 | 0.5813 | 0.4454 |
MCF7 | Sirolimus | 0.37 | uM | LJP6 | 72 | hr | 1389 | 3167 | 5667 | 0.5589 | 0.4157 |
MCF7 | Sorafenib | 0.37 | uM | LJP6 | 72 | hr | 1389 | 4946 | 5667 | 0.8726 | 0.8313 |
MCF7 | SU11274 | 0.37 | uM | LJP5 | 72 | hr | 1389 | 5969 | 5667 | 1.0532 | 1.0705 |
MCF7 | Fedratinib | 0.37 | uM | LJP5 | 72 | hr | 1389 | 5460 | 5667 | 0.9634 | 0.9515 |